Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dong-bin Peng
TSSC3 Promotes Autophagy via Inactivating the SRC-Mediated PI3K/Akt/mTOR Pathway to Suppress Tumorigenesis and Metastasis in Osteosarcoma, and Predicts a Favorable Prognosis
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Related publications
TrkB Promotes Laryngeal Cancer Metastasis via Activation PI3K/AKT Pathway
Oncotarget
Oncology
Spironolactone Promotes Autophagy via Inhibiting PI3K/AKT/mTOR Signalling Pathway and Reduce Adhesive Capacity Damage in Podocytes Under Mechanical Stress
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Hydrogen Sulfide Promotes Autophagy of Hepatocellular Carcinoma Cells Through the PI3K/Akt/mTOR Signaling Pathway
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
ANXA6 Contributes to Radioresistance by Promoting Autophagy via Inhibiting the PI3K/AKT/mTOR Signaling Pathway in Nasopharyngeal Carcinoma
Frontiers in Cell and Developmental Biology
Developmental Biology
Cell Biology
Angelica Sinensis Promotes Myotube Hypertrophy Through the PI3K/Akt/mTOR Pathway
BMC Complementary and Alternative Medicine
Medicine
Alternative Medicine
Complementary
HSPC159 Promotes Proliferation and Metastasis via Inducing EMT and Activating PI3K/Akt Pathway in Breast Cancer
Cancer Science
Cancer Research
Medicine
Oncology
MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway
OncoTargets and Therapy
Oncology
Pharmacology
Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway
Frontiers in Oncology
Cancer Research
Oncology
Genipin Induces Autophagy and Suppresses Cell Growth of Oral Squamous Cell Carcinoma via PI3K/AKT/MTOR Pathway
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
